1Revenue grew 129.4% to $245.0K, primarily due to an increase in revenue recognized through Sellavir, while the legacy detection equipment business was wound down.
2Gross profit increased 156.1% to $101.6K, with gross margin improving to 41.5%, reflecting the shift toward software development.
3Operating losses deepened to -$291.4K (-40.9% year-over-year) as an increase in operating expense overwhelmed revenue gains, contributing to a net loss of -$256.9K.
4The company's ability to compete depends on technology effectiveness, platform integration, solution scalability, and securing customers and partnerships in its high-risk transition.
5Management is evaluating plans to address the going concern, including focusing on the CenterEye platform and seeking partnerships, but there is no assurance these will succeed.